Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
Humana Star Ratings Plunge Is Latest in Recent Medicare Setbacks
Johnson & Johnson's Options: A Look at What the Big Money Is Thinking
Companies Heavily Investing in AI Have Low Quant Valuation Grades
Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
Decoding UnitedHealth Group's Options Activity: What's the Big Picture?
Understanding UnitedHealth Group's Position In Health Care Providers & Services Industry Compared To Competitors
Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
J&J Prostate Cancer Therapy Outperforms in Real-world Study
Bristol-Myers Tops Growth Chart Among S&P 500 Healthcare Stocks in Q3
Humana's Stock Rocked After a Medicare Advantage Plan's Rating Is Set to Drop
Sector Update: Health Care Stocks Flat to Lower Pre-Bell Wednesday
Johnson & Johnson Presents Results From Study Showing That ERLEADA Demonstrates Statistically Significant And Clinically Meaningful Improvement In Overall Survival Compared To Enzalutamide In Patients With Metastatic Castration-sensitive Prostate Cancer
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday as Investors Exercise Caution Amid Mid-East Tensions
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could Be Next
The Covid Era Tech Promises To Reinvent Cancer Treatment
AbbVie Withdraws Exviera From EU Market for Commercial Reasons
Intuitive Surgical Analyst Ratings
Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $591 Price Target